In the case of familial melanoma, germline inactivating mutations in the CDKN2A/B locus (mainly p16 and p14) are common (Straume et al., 2002; Gast et al., 2010), leading to aberrant CDK4/cyclin D activity that drives melanoma cell cycle progression. The gene discussed is CDK4; the disease is melanoma.